Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

Completed · Phase 3

Conditions studied: Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients being treated with chemotherapy. PURPOSE: This randomized phase III trial is comparing how well different antiemetic drugs work in preventing delayed nausea after chemotherapy in patients who have cancer.

Key facts

Study ID

NCT00020657

Run by

Gary Morrow

Starts

2001-07-01

Expected to finish

2004-10-01

Last updated by the study team

2015-10-15

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• MBCCOP - Gulf Coast — Mobile, Alabama, United States
• CCOP - Western Regional, Arizona — Phoenix, Arizona, United States
• CCOP - Mayo Clinic Scottsdale Oncology Program — Scottsdale, Arizona, United States
• CCOP - Colorado Cancer Research Program, Incorporated — Denver, Colorado, United States
• MBCCOP - Hawaii — Honolulu, Hawaii, United States
• CCOP - Central Illinois — Decatur, Illinois, United States
• CCOP - Wichita — Wichita, Kansas, United States
• CCOP - Kalamazoo — Kalamazoo, Michigan, United States
• CCOP - Northern New Jersey — Hackensack, New Jersey, United States
• CCOP - North Shore University Hospital — Manhasset, New York, United States
• CCOP - Southeast Cancer Control Consortium — Winston-Salem, North Carolina, United States
• CCOP - Columbus — Columbus, Ohio, United States
• CCOP - Dayton — Dayton, Ohio, United States
• CCOP - Greenville — Greenville, South Carolina, United States
• CCOP - Northwest — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.